Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study.
Matthew N KleinElizabeth Wenqian WangPaul ZimandHeather BeauchampCaitlin DonisMatthew D WardAidaelis Martinez-HernandezAli TabatabaiJohn W BaddleyEvan M BlochKristin E MullinsMagali J FontainePublished in: Journal of clinical pathology (2021)
CCP transfusion did not increase the kinetics of SARS-CoV2 antibodies and did not result in improved clinical outcomes in patients with COVID-19 with severe respiratory failure, suggesting that CCP may not be indicated in this category of patients.
Keyphrases
- sars cov
- respiratory failure
- extracorporeal membrane oxygenation
- mechanical ventilation
- respiratory syndrome coronavirus
- coronavirus disease
- end stage renal disease
- cardiac surgery
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early onset
- acute respiratory distress syndrome
- prognostic factors
- intensive care unit
- patient reported outcomes